Chong Yuh Ping, Lim Say Min, Loh Tze Ping, Mollee Peter, Wijeratne Nilika, Choy Kay Weng
School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.
Department of Pathology, Hospital Teluk Intan, Teluk Intan, Malaysia.
J Clin Pathol. 2023 Nov;76(11):727-733. doi: 10.1136/jcp-2023-208774. Epub 2023 Aug 21.
Monoclonal gammopathy is a spectrum of disorders characterised by clonal proliferation of plasma cells or lymphocytes, which produce abnormal immunoglobulin or its components (monoclonal proteins). Monoclonal gammopathies are often categorised as low-tumour-burden diseases (eg, amyloid light chain (AL) amyloidosis), premalignant disorders (such as monoclonal gammopathy of undetermined significance and smouldering multiple myeloma), and malignancies (eg, multiple myeloma and Waldenström's macroglobulinaemia). Such diversity of concentration and structure makes monoclonal protein a challenging clonal marker. This article provides an overview on initial laboratory testing of monoclonal gammopathy to guide clinicians and laboratory professionals in the selection and interpretation of appropriate investigations.
单克隆丙种球蛋白病是一系列以浆细胞或淋巴细胞克隆性增殖为特征的疾病,这些细胞会产生异常免疫球蛋白或其成分(单克隆蛋白)。单克隆丙种球蛋白病通常被归类为低肿瘤负荷疾病(如淀粉样轻链(AL)淀粉样变性)、癌前疾病(如意义未明的单克隆丙种球蛋白病和冒烟型多发性骨髓瘤)以及恶性肿瘤(如多发性骨髓瘤和华氏巨球蛋白血症)。单克隆蛋白在浓度和结构上的这种多样性使其成为一种具有挑战性的克隆标志物。本文概述了单克隆丙种球蛋白病的初始实验室检测,以指导临床医生和实验室专业人员选择和解读适当的检查。